Clinical Trials Browser

Terminated × Neoplasm Metastasis × Tamoxifen × Clear all

NCT00684216 2017-09-14

Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

Phase 2/3 Terminated

Breast Neoplasms, Neoplasm Metastasis

NCT00532454 2010-02-10

Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen

Phase 2 Terminated

Breast Neoplasms, Neoplasm Metastasis